Please assess the completion status of the following clinical trial:

Trial Title: Phase I Safety Trial of Streptococcus Pneumoniae Whole Cell Vaccine (SPWCV) + Alum in Healthy Adults

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE1
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria, Healthy adults:~* If female, not breastfeeding, not pregnant, not planning pregnancy during study period), and willing to consistently use an adequate method of contraception and have repeated pregnancy tests.~* In good health with normal laboratory results~* Willing to comply with study restrictions, study schedule, and can be reliably contacted~Exclusion Criteria:~* Currently consumes alcohol in excess of 2 drinks per day for men or 1 drink per day for women.~* current use or likely requirement for medications with potential for liver injury or effect immune system~* History of event or condition such as anaphylaxis, severe allergic reactions, serious reactions to any vaccines, or other events that might increase risk of reaction to an investigational disease~* History of diabetes, cancer, autoimmune or immunosuppressive disease or chronic such as HIV, Hepatitis B or C

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- Cohort 1 SPWCV+Alum 100 mcg (Type: EXPERIMENTAL): each individual receiving 3 vaccinations of same dose 28 days apart
- Cohort 2 SPWCV+Alum 300 mcg (Type: EXPERIMENTAL): each individual receiving 3 vaccinations of same dose 28 days apart
- Cohort 3 SPWCV+Alum 600 mcg (Type: EXPERIMENTAL): each individual receiving 3 vaccinations of same dose 28 days apart
- Normal Saline Injection (Type: PLACEBO_COMPARATOR): placebo group within each cohort receive 3 injections of normal saline 28 days apart~normal saline injection: 3 cohorts of normal saline injection

Based on this trial design, predict the completion outcome and termination type (if applicable).